Yale Researchers Identify Tumor Reactive Immune Cells to Help Fight Against Advanced Melanoma
March 03, 2021
March 03, 2021
NEW HAVEN, Connecticut, March 3 (TNSJou) -- Yale School of Medicine issued the following news on March 2, 2021:
According to a new study led by Yale Cancer Center and Department of Neurology researchers, a simple blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma, a deadly form of skin cancer. The findings were published today in the Journal of Experimental Medicine.
"These results are important becau . . .
According to a new study led by Yale Cancer Center and Department of Neurology researchers, a simple blood draw may be the first step in helping to discover tumor reactive immune or T cells to treat advanced melanoma, a deadly form of skin cancer. The findings were published today in the Journal of Experimental Medicine.
"These results are important becau . . .